Skip to Main Content

Paper Details

Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403).
Clin Cancer Res
16
2022
Author NameAffiliation
Roy S HerbstYale School of Medicine and Yale Cancer Center
  • 1 - 1

Datasets

Release 1.2